← Back to Search

Behavioural Intervention

Exercise Programs for COPD (CLD Trial)

N/A
Recruiting
Led By Shweta Gore, PhD
Research Sponsored by MGH Institute of Health Professions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 4 months follow up
Awards & highlights

Summary

This trial aims to compare the effectiveness of a supervised exercise program delivered either onsite or through telehealth for adults with COPD. The study will evaluate outcomes such as breathlessness, exercise capacity, physical function

Who is the study for?
This trial is for adults with COPD who have completed traditional exercise or physical therapy. They must be able to participate in an 8-week supervised maintenance exercise program either onsite or through telehealth. There's no detailed exclusion criteria provided, but typically those unable to perform exercises or follow the protocol may not qualify.
What is being tested?
The study aims to compare two types of maintenance exercise programs for COPD patients: one conducted onsite and the other via telehealth, against a control group receiving biweekly check-ins without active intervention. The focus is on measuring breathlessness, exercise capacity, physical function, activity levels, and quality of life.
What are the potential side effects?
Since this trial involves exercise programs rather than medication, side effects might include muscle soreness, fatigue from workouts or potential exacerbation of COPD symptoms due to increased activity levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 4-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 4-month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dyspnea
Exercise Capacity
Physical Function
+1 more
Secondary study objectives
Adverse events
Healthcare utilization
Inspiratory muscle strength
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth Pulmonary RehabExperimental Treatment1 Intervention
Supervised pulmonary rehabilitation including exercise training, activity counselling, and education provided remotely using Zoom videoconferencing technology.
Group II: Onsite Pulmonary RehabExperimental Treatment1 Intervention
Supervised pulmonary rehabilitation including exercise training, activity counselling, and education provided onsite.
Group III: ControlActive Control1 Intervention
Control group participants will only be seen during the outcomes assessments at the MGH Institute of Health Professions at times 0, 1, and 2, but will receive no active supervised intervention. Control group participants will go home with discharge instructions to maintain a home exercise routine provided to them at discharge. Bi-weekly check in phone calls from the study team will continue to ensure participant engagement in the study. During the phone calls, participants will be encouraged to keep a log of their weekly activities in a journal.

Find a Location

Who is running the clinical trial?

MGH Institute of Health ProfessionsLead Sponsor
16 Previous Clinical Trials
3,663 Total Patients Enrolled
Shweta Gore, PhDPrincipal InvestigatorMGH Institute of Health Professions
~17 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top